Skip to main content
FinSpry Logo
FinSpry
LXRX logo
LXRX
(NASDAQ)
Lexicon Pharmaceuticals, Inc.
$2.32-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Lexicon Pharmaceuticals (LXRX) Stock Price & Financial Analysis

Lexicon Pharmaceuticals Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$2.17 - $2.40
52-Week High$2.68
52-Week Low$1.03
Open$2.40
Volume4.74M
Average Volume (3M)2.87M
Market Cap920.55M
Shares Outstanding400.24M
Price to Sales (P/S)13.45
Price to Book (P/B)4.62
EV/EBITDA-54.82
Revenue (TTM)69.64M
Net Income (TTM)-26.09M
Free Cash Flow (TTM)-38.80M
EPS (TTM)$-0.07
Profit Margin-37.46%
Operating Margin-34.79%
Return on Equity (ROE)-12.86%
Debt to Equity0.28
50-Day MA$2.25
200-Day MA$1.72
52-Week Change88.71%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Lexicon Pharmaceuticals

What is the current stock price for LXRX?

As of the latest trading session, LXRX stock trades at $2.18. The 52-week range is $1.03–$2.68, with a day range of $2.17–$2.40.

What is the P/E ratio for LXRX?

The P/E ratio (Price-to-Earnings) for LXRX is shown in the Key Statistics section. This valuation metric helps compare Lexicon Pharmaceuticals, Inc. to industry peers.

Does LXRX pay dividends?

Lexicon Pharmaceuticals does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for LXRX?

Based on 2 analysts, the consensus for LXRX is Buy.

What is the market cap of LXRX?

Lexicon Pharmaceuticals's market capitalization is $872.5M, classifying it as a small-cap company. Lexicon Pharmaceuticals operates in the Healthcare sector within the Biotechnology industry.